DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /PyrrolidinesPyrrolidines
  6. /E3 Ligase Ligand-linker Conjugate 122CAS 3033187-29-7
Chemical structure of CAS 3033187-29-7

E3 Ligase Ligand-linker Conjugate 122

CAS No.3033187-29-7
MDL No.N/A
MFC33H48N8O5S
MW668.90
InChI KeyGAKYUEMFKVDDRM-RVSRZYBWSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.3033187-29-7
Product NameE3 Ligase Ligand-linker Conjugate 122
Heavy Atom Count47Rotatable Bond Count16
Atom Stereo Count4Bond Stereo Count0
HBA8HBD4
TPSA189.490 ŲCharge0
Exact Mass668.34684Complexity1416.72
pKa7.130XLogP4.556

Documentation

Similar Products

  • (S,R,S)-AHPC-amido-C5-acid

    CAS No.2162120-87-6

  • VH 032 amide-alkylC6-acid

    CAS No.2172819-75-7

  • L-Prolinamide, 3-methyl-L-valyl-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-, (4R)-

    CAS No.1948273-02-6

  • (2S,4R)-1-((S)-2-(6-Aminohexanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride

    CAS No.2170695-20-0

  • PROTAC CYP1B1 degrader-2

    CAS No.2836297-26-6

  • Protac linker 5

    CAS No.2245697-83-8

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact